Hepatocellular adenomas (HCA) are benign liver tumors predominantly developed in
women using oral contraceptives. Here, exome sequencing identified recurrent somatic FRK …

Focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) are benign
hepatocellular tumors that develop most frequently in women without cirrhosis. Genomic …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. It is more
prevalent in men than women. Related to this, recent genetic studies have revealed a causal …

Hepatocellular carcinomas (HCCs) are a heterogeneous group of tumors that differ in risk
factors and genetic alterations. We further investigated transcriptome‐genotype‐phenotype …

Background & Aims Development of hepatocellular carcinoma (HCC) is associated with
alterations in the transforming growth factor-beta (TGF-β) signaling pathway, which …

Background & Aims Hepatocellular adenomas (HCAs) are benign liver tumors that can be
assigned to molecular subtypes based on inactivating mutations in hepatocyte nuclear factor …

Focal nodular hyperplasia (FNH) and hepatocellular adenomas (HCAs) are benign tumors
that occur in otherwise normal liver parenchyma. FNH is considered to be the result of a …

Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading
cause of cancer deaths worldwide. Proper classification and early identification of HCC and …

Background & Aims Hepatoblastoma (HB) is the most common childhood liver cancer and
occasionally presents with histological and clinical features reminiscent of hepatocellular …

Genomic analyses promise to improve tumor characterization to optimize personalized
treatment for patients with hepatocellular carcinoma (HCC). Exome sequencing analysis of …